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How much does the survival of one group differ from the
survival of another group? How do differences in age in these
two groups affect such a comparison? To obtain a quantity to
compare the survival of different patient groups and to
account for confounding effects, a multiple regression
technique for survival data is needed. Cox regression is
perhaps the most popular regression technique for survival
analysis. This paper explains how Cox regression works, what
the proportionality assumption means and how to interpret
the results of univariate and multiple Cox regression models.
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The previous publication in this series outlined the funda-
mental concepts of survival analysis. It introduced the
Kaplan–Meier method to produce survival tables and graphs
of the cumulative survival, and the logrank test to calculate a
P-value for the comparison of groups.1 This method is
adequate if the goal is to explore the survival of populations
under investigation and to give a basic and unadjusted
description of the data. However, if the goal is to investigate
the relation between exposure to risk factors and clinical
outcomes, investigators aim to obtain a measure of effect and
to account for confounding factors.2
The Cox regression model is probably the most popular
regression technique for regression analysis of survival
data.3,4 As will be discussed in a future article in this series,
it can be used for risk stratification and prognostic modeling.
In this article, however, we introduce the Cox regression
technique and describe how to interpret the statistical results
in the context of etiological studies. In this respect, we
explain how this technique can be used to obtain a crude
relative risk for a risk factor of mortality, and how to adjust
this for one or more confounding factors.
THE REGRESSION ‘FAMILY’
The causal relationship between explanatory variable(s) and
outcome is commonly investigated in epidemiology. An
investigator may, for example, be interested in the relation-
ship between the explanatory variable serum albumin and the
dependent variable-free triiodothyronine (plasma levels of
fT3).5 As in this example the outcome variable is continuous,
a linear regression model would be a suitable choice to model
these data. Suppose instead that the investigator is interested
in the relationship between BMI and the risk to develop
chronic kidney disease, then logistic regression would be the
method to choose.6 Analogous to these two types of
regression (the first for continuous and the second for
dichotomous outcomes),7 a Cox regression model can be
used to assess the relationship between one ore more
explanatory variable(s) and the time to the occurrence of
an event (for example, BMI and time to death). This type of
analysis is referred to as survival analysis. In the previous
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publication in this series on epidemiology, it was outlined
that in survival data at the end of the follow-up period, the
event will probably not have occurred for all patients.1 If, for
example, some patients are still alive at the end of a study or
some are lost to follow-up, the survival times for such cases
are called censored. The ability to account for censored
observations is what distinguishes Cox regression from linear
and logistic regression.
As shown in Table 1, all regression models are defined by the
basic parameters b0 (intercept or constant) and b1 (beta or
slope). Together, these two parameters describe the relationship
between the explanatory and the outcome variable. In linear
regression, a linear relationship between the explanatory (serum
albumin) and the outcome variable (plasma levels of fT3) is
assumed. According to this linear function, each unit of change
in serum albumin would cause a fixed change in the plasma
levels of fT3. The direction and magnitude of this change is
quantified by the beta (b1). As has been shown in the article by
Tripepi et al.,7 a regression coefficient of 1.36 means that for
each 1 g per 100 ml change in serum albumin, there is a
corresponding change of 1.36 pg/ml in plasma fT3. The
intercept (b0) is the point where the regression line crosses
the y axis (the theoretical value of Y if X equals zero). In the
example of Tripepi et al., it can be applied, together with the
regression coefficient, to predict the estimated value of plasma
fT3 for a given individual whose corresponding serum albumin
concentration is known. Logistic regression works in a similar
way but then the outcome is the logarithm of the odds of the
event to occur. To be able to interpret the equation for logistic
regression (see Table 1), both sides could be raised to the power.
For example, if in the relationship between BMI and the risk to
develop chronic kidney disease the beta is estimated to be 1.118,
then the odds ratio of one unit increase of BMI is e1.118¼ 3.06.
Further details on linear and logistic regression have been
outlined in a previous article in this series.7 The quantity that is
modeled in Cox regression is the incidence rate that may vary
over time. A step-by-step explanation of the incidence rate, how
it is modeled in Cox regression, and the interpretation of its
estimates is provided below.
INCIDENCE RATE
In a previous article, the concept of incidence rate was
explained as the ratio of the number of subjects developing
disease (or other health outcome) to the time at risk for
disease.8 In that article, it was outlined that incidence rate is
an instantaneous concept, similar to speed. Along similar
lines in survival analysis, the incidence rate (or hazard) of
death, ‘the force of mortality’, is studied as the number of
events related to the time at risk of death. Similar to the fact
that the speed in car driving will never be constant, it should
be noted that the incidence rate of death in survival analysis
may also vary with time. In the context of Cox regression, the
incidence rate is usually referred to as the hazard. In this
article, both terms are used interchangeably.
Example. Renal replacement therapy for diabetic end-stage
renal disease
Incident dialysis patients in the ERA-EDTA Registry were
included in an analysis of patient survival on dialysis by
diabetic status.9 Similar to most survival studies, patients were
recruited over a period of time (1996–2000: the inclusion
period) and they were observed up to a specific date (31
December 2005: the end of the follow-up period). The death of
the patient was the event studied. Transplantation and recovery
of renal function were censored observations. For all patients,
the covariates age and diabetes were collected at the start of
renal replacement therapy. Appendix 1 shows the basic data
layout of the data set that was used in this study.
Figure 1 shows the incidence rate (left panel) of death in a
sample of 2500 dialysis patients, which was taken from the
original data set that was used in this study. It can be seen easily
that the hazard rate varies slightly over time. Derived from this
incidence rate is the cumulative survival function (right panel).
The hazard rate and the cumulative survival provide alternative
but equivalent characterizations of the distribution of survival
time. Although most readers will be more familiar with the
description of the distribution of survival data in terms of
cumulative survival (which is the probability that a patient will
survive beyond time t.), in Cox regression, the hazard (or
incidence) rate is the quantity that is being modeled. In the
remainder of this article, the distribution of survival times is
therefore expressed in terms of the hazard rate.
The equation for a basic Cox regression model is usually
written as follows:
hiðtÞ ¼ l0ðtÞ  expfb1x1g
This equation tells us that the hazard for individual i at time t
is the product of two quantities:
(1) The baseline hazard function: l0(t)
(2) A linear function of covariate(s), which is exponentiated:
b1xi
Table 1 | The regression family
Linear regression Y=b0+b1xi
Logistic regression ln(P/(1P)=b0+b1xi
Cox regressiona lnincidence(t)=b0(t)+b1xi
aThe standard notation for Cox regression is: hi(t)=l0(t) exp{b1xi}.
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Figure 1 | The left panel shows the incidence rate of death
which varies over time. The right panel shows the cumulative
survival which is derived from the incidence rate of the left panel.
(a) The hazard function and (b) the cumulative survival function
for 2500 dialysis patients.
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By taking the logarithm of both sides, the equation becomes
ln ðhiðtÞÞ ¼ l0ðtÞ þ fb1xig
A slight change in terminology and notation results in the
equation of Table 1:
lnincidence ðtÞ ¼ b0ðtÞ þ b1xi
This reworked equation looks more familiar to the equations
of the linear and logistic regression model and is easier to
interpret.
The time-varying intercept b0(t) can be considered as the
log of the baseline hazard that applies to those (theoretical)
cases for which the values of all covariates are fixed at zero.
For example, if in the sample of 2500 patients there would be
diabetics and nondiabetics, then the b0(t) would be the log of
the incidence rate of cases without diabetes (which are coded
as zero). The log of the incidence rate of cases with diabetes
(which are coded as one) would then be the sum of the
baseline hazard, b0(t), and the estimated beta, b1 for diabetes.
This is illustrated in the upper panel of Figure 2. It shows the
log incidence rate for diabetic (dashed line) and nondiabetic
patients (solid line) plotted as a function of time. According
to this figure, the incidence of dying is higher in diabetics
than in nondiabetics. The lower panel of Figure 2 shows the
related cumulative survival functions for both patient groups.
As the hazard of mortality is higher in diabetics (upper
panel), the cumulative survival in those patients is lower
(lower panel). If x represents the covariate diabetes, then the
Cox regression equation in this example is
lnincidence ðtÞ ¼ b0ðtÞ þ b1x
The Cox regression equations for each group separately are
diabetics (x¼ 1): ln[inc 1] (t)¼ b0(t)þ b1.1¼ b0(t)þ b1
non diabetics (x¼ 0): ln[inc 0] (t)¼ b0(t)þ b1.0¼ b0(t)
By subtracting both equations, the intercept part b0 with its
time component (t) cancel out. Thus, after subtracting, the
difference in lnincidence does not depend on time anymore.
Therefore, the equation becomes
ln½inc1
  ln½inc0
 ¼ b1
which is the vertical distance between the two functions of
Figure 2.
Remember that this equation represents the difference on
a logarithmic scale. If both sides of the equation are
exponentiated, a ratio of the incidence of both groups
(diabetics/nondiabetics) will be obtained, as a property
of logarithms is that they turn division into subtraction
(ln x/y¼ lnxlny):
eðln½inc1
  ln½inc0
Þ ¼ eb1 ! ½inc1
=½inc0
 ¼ eb1
In words, this means that the exponent of b1 is the ratio of
the incidence rate of death for diabetics and the incidence
rate of death for nondiabetics. This ratio, which is called the
hazard ratio quantifies the impact of diabetes on outcome
and can be interpreted as a relative risk type of ratio.10 A
hazard ratio above 1 indicates a covariate that is positively
associated with the event probability, and thus negatively
associated with the length of survival.
In summary, the Cox model is a multiple linear regression
of the logarithm of the incidence rate on the variables Xi,
with the baseline incidence rate being an ‘intercept’ term that
varies with time.11
PROPORTIONALITY
Often the Cox regression model is called the proportional
hazards (PH) model. The reason for this is that the standard
model assumes that the excess risk (the vertical distance
between the log of the incidence rate of both groups) between
the two groups is constant throughout the follow-up time.
This fact is the reason that the hazard ratio has such a simple
and useful interpretation. Although in practice it is unlikely
that the proportional hazards assumption is ever fully
satisfied, important violation of the PH assumption may
result in wrong and misleading estimates.
Often crossing survival curves are a strong indication of
nonproportionality. But still even if they do not cross but
converge or diverge with time, nonproportionality may be a
problem.
There are two popular approaches to test the presence of
nonproportional hazards: the first is the graphical inspection of
the incidence rates, and the second, which is more powerful
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Figure 2 | The upper panel shows the log incidence rate for
diabetic and non-diabetic patients as a function of time.
The lower panel shows the cumulative survival funcions for both
patient groups. (a) The hazard function and (b) the cumulative
survival function for 2500 dialysis patients by diabetic status.
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and objective, is extending the Cox model by introducing an
interaction of the covariate of interest with time. To start with
the first, plotting the incidence rate functions of contrasting
groups is a quick (but subjective) way to investigate whether
the proportionality assumption holds true. For example, a
visual inspection of Figure 2 (upper panel) learns that the log of
the incidence rates of diabetics and nondiabetics are reasonably
parallel, and therefore in that example the PH assumption was
probably fulfilled. In other situations, however, this may be not
so obvious. In such a case, the second approach, the
introduction of an interaction term of the covariate of interest
with time, is a diagnostic solution, which at the same time
cures the problem. In this approach, the PH assumption can be
checked by testing for the significance of the interaction term.
A statistically significant interaction term then means that the
main effect is not proportional with time. As the PH
assumption is so vital to the interpretation of a Cox regression
model, it is recommended to consult a statistician to find a
suitable solution in case the assumption is not satisfied. For
further information on the tools and methods to check the
proportional hazards assumption, we refer to dedicated
textbooks on survival analysis.12–15
INTERPRETATION OF THE COX REGRESSION MODEL
Cox regression with a single covariate
Cox regression analysis was performed on the data of 2500
patients with diabetes as a single covariate. Diabetes was
coded as a binary variable with a zero for nondiabetics and a
one for diabetics. The results of the model are shown in
Table 2. A first feature to note is the sign of the regression
coefficient (the beta) for diabetes. In this case, the beta is
positive (0.54), which means that the log of the incidence rate
for death in diabetics is higher than in nondiabetic patients.
Thus, the hazard ratio for diabetics compared with
nondiabetics is e0.54¼ 1.71, which also indicates that the
mortality of diabetics is higher than that of nondiabetics.
Multiple Cox regression
As confounding obscures the ‘real’ effect of an exposure on
outcome, investigators performing etiological studies do their
utmost best to prevent or control confounding.2 As has been
mentioned, Cox regression is the tool to account for
confounding effects when performing survival analysis. In
Table 2, the impact of diabetes on survival was assessed without
accounting for any potential confounders. From a clinical
background, one would, however, expect that age obscures the
relationship between diabetes and survival, as diabetics are
usually younger and younger people have lower mortality.
Therefore, in addition to diabetes, the continuous covariate age
is entered in the Cox regression model as well. Table 3 shows
the output of this multiple Cox regression model. The results
show an effect of both age and diabetes. Compared with the
univariate model of Table 2, the hazard ratio for diabetes
increased from 1.711 to 1.939. This change shows that after
accounting for the confounding effect of age, the impact of
diabetes on survival is even stronger. The output shows that the
diabetes-adjusted hazard ratio for age is 1.048. However, from
an etiological point of view, the direct impact of age on survival
is not so interesting in this example. After all, the variable age
was only introduced in the model to account for its
confounding effect on the diabetes—survival relationship.
CONCLUSION
Cox regression is a powerful and popular regression
technique to study the impact of several risk factors on
survival at the same time. This article described some basic
properties and applications of the Cox regression model in
the context of etiological studies. It discussed the propor-
tionality assumption and how this assumption can be
checked. If the survival curves cross, the Cox regression
model with proportional hazards is inappropriate and
extensions to the Cox model are needed. Further extensions
of the Cox regression technique, for example, the modeling of
time-dependent effects will be described in detail in the next
article in this series.
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Table 2 | Output of the Cox regression model for diabetic status
Estimates
Variable Beta Standard error P-value Hazard ratio exp(Beta) 95% confidence interval
Diabetes (yes/no) 0.537 0.068 o0.0001 1.711 1.498 1.954
Table 3 | Output of the Cox regression model for diabetic status and age
Estimates
Variable Beta Standard error P-value Hazard ratio exp(Beta) 95% confidence interval
Age (continuous) 0.047 0.002 o0.0001 1.048 1.043 1.053
Diabetes (yes/no) 0.662 0.068 o0.0001 1.939 1.696 2.216
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Appendix 1
Basic data layout of the data set
Patient number Age at start in years (X1) Diabetes at start (0=no, 1=yes) (X2) Survival time (in years) Event (died, 0=no, 1=yes)
1 36.10 0 0.99 0
2 61.93 1 1.48 0
3 60.64 0 0.85 1
4 43.73 1 2.35 0
5 44.73 0 3.00 0
6 68.08 0 2.95 1
7 45.81 0 2.68 0
8 47.69 0 3.00 0
9 66.57 0 1.74 1
10 15.45 0 0.00 0
y y y y y
2500 y y y y
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